TRACON Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-5.202; its P/E ratio is -0.41; TRACON Pharmaceuticals is scheduled to report earnings on May 15, 2024, and the estimated EPS forecast is $-1.19. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 3.04M	-	$ 9.00M	-	-
Gross Profit	$ 3.04M	-	$ 9.00M	-	-
EBIT	$ 464.00K	$ 6.76M	$ 2.46M	$ -7.32M	$ -6.08M
EBITDA	$ 471.00K	$ 7.44M	$ 8.01M	$ -6.18M	$ -5.65M
Net Income Common Stockholders	$ -4.31M	$ 6.76M	$ -6.29M	$ -8.50M	$ -7.00M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 8.56M	$ 7.76M	$ 1.74M	$ 6.61M	$ 17.43M
Total Assets	$ 10.11M	$ 9.41M	$ 12.15M	$ 8.36M	$ 19.47M
Total Debt	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 9.81M
Net Debt	$ -8.56M	$ -7.76M	$ -1.74M	$ -6.61M	$ -7.63M
Total Liabilities	$ 10.91M	$ 12.50M	$ 27.93M	$ 19.39M	$ 26.62M
Stockholders Equity	$ -809.00K	$ -3.08M	$ -15.74M	$ -11.06M	$ -7.15M
Cash Flow	-
Free Cash Flow	$ -522.00K	$ 15.05M	$ -5.85M	$ -5.00M	$ -4.66M
Operating Cash Flow	$ -522.00K	$ 15.05M	$ -5.85M	$ -5.00M	$ -4.65M
Investing Cash Flow	-	-	-	-	$ -4.00K
Financing Cash Flow	$ 1.32M	$ -9.09M	$ 1.05M	$ -5.82M	$ 4.95M

Currency in USD

TRACON Pharmaceuticals Earnings and Revenue History

Income Statement >

TRACON Pharmaceuticals Debt to Assets

Balance Sheet >

TRACON Pharmaceuticals Cash Flow

Cash Flow >

TRACON Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing